tripelennamine has been researched along with Anochlesia in 1 studies
Tripelennamine: A histamine H1 antagonist with low sedative action but frequent gastrointestinal irritation. It is used to treat ASTHMA; HAY FEVER; URTICARIA; and RHINITIS; and also in veterinary applications. Tripelennamine is administered by various routes, including topically.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maśliński, C | 1 |
| Lebrecht, U | 1 |
| Nowak, JZ | 1 |
| Pilc, A | 1 |
| Wieczorek-Fila, Z | 1 |
1 other study available for tripelennamine and Anochlesia
| Article | Year |
|---|---|
Catalepsia-like symptoms produced by histidine in rats.
Topics: Amodiaquine; Animals; Catalepsy; Chlorpromazine; Histidine; Humans; Imidazoles; Methyltransferases; | 1973 |